These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 38779731)
41. Prediction of risk and clinical outcome of cuproptosis in lung squamous carcinoma. Zhang Y; Zhou J; Li H; Liu Y; Li J BMC Pulm Med; 2023 Jun; 23(1):205. PubMed ID: 37308925 [TBL] [Abstract][Full Text] [Related]
42. Prognostic value of cuproptosis-related genes signature and its impact on the reshaped immune microenvironment of glioma. Chen S; Zhang S; Yuan Y; Wang Z; Li J; Li T; Zuo M; Feng W; Chen M; Liu Y Front Pharmacol; 2022; 13():1016520. PubMed ID: 36267281 [TBL] [Abstract][Full Text] [Related]
43. Identification of diagnostic markers and molecular clusters of cuproptosis-related genes in alcohol-related liver disease based on machine learning and experimental validation. Li J; Wang Y; Wu Z; Zhong M; Feng G; Liu Z; Zeng Y; Wei Z; Mueller S; He S; Ouyang G; Yuan G Heliyon; 2024 Sep; 10(18):e37612. PubMed ID: 39315155 [TBL] [Abstract][Full Text] [Related]
44. Relationships of Cuproptosis-Related Genes With Clinical Outcomes and the Tumour Immune Microenvironment in Hepatocellular Carcinoma. Chen X; Hu G; Xiong L; Xu Q Pathol Oncol Res; 2022; 28():1610558. PubMed ID: 36213162 [No Abstract] [Full Text] [Related]
45. A novel cuproptosis-related subtypes and gene signature associates with immunophenotype and predicts prognosis accurately in neuroblastoma. Tian XM; Xiang B; Yu YH; Li Q; Zhang ZX; Zhanghuang C; Jin LM; Wang JK; Mi T; Chen ML; Liu F; Wei GH Front Immunol; 2022; 13():999849. PubMed ID: 36211401 [TBL] [Abstract][Full Text] [Related]
46. Identification of Cuproptosis Clusters and Integrative Analyses in Parkinson's Disease. Zhang M; Meng W; Liu C; Wang H; Li R; Wang Q; Gao Y; Zhou S; Du T; Yuan T; Shi L; Han C; Meng F Brain Sci; 2023 Jun; 13(7):. PubMed ID: 37508947 [TBL] [Abstract][Full Text] [Related]
47. Molecular Subtypes Based on Cuproptosis-Related Genes and Tumor Microenvironment Infiltration Characterization in Colorectal Cancer. Huang H; Long Z; Xie Y; Qin P; Kuang L; Li X; Zhao Y; Zhang X; Yang L; Ma W; Xiao X; Liu Y; Sun X; Zhang M; Wang F; Hu D; Hu F J Oncol; 2022; 2022():5034092. PubMed ID: 36276275 [TBL] [Abstract][Full Text] [Related]
48. Cuproptosis-related molecular patterns and gene (ATP7A) in hepatocellular carcinoma and their relationships with tumor immune microenvironment and clinical features. Li S; Weng J; Xiao C; Lu J; Cao W; Song F; He Z; Zhang P; Zhu Z; Xu J Cancer Rep (Hoboken); 2023 Dec; 6(12):e1904. PubMed ID: 37885090 [TBL] [Abstract][Full Text] [Related]
49. Exploring the role of LIAS-related cuproptosis in systemic lupus erythematosus. Li Y; Xu B; Zhang J; Liu X; Ganesan K; Shi G Lupus; 2023 Dec; 32(14):1598-1609. PubMed ID: 37903189 [TBL] [Abstract][Full Text] [Related]
50. Identification and immunological characterization of cuproptosis-related molecular clusters in idiopathic pulmonary fibrosis disease. Shi X; Pan Z; Cai W; Zhang Y; Duo J; Liu R; Cai T Front Immunol; 2023; 14():1171445. PubMed ID: 37266442 [TBL] [Abstract][Full Text] [Related]
51. Comprehensive analysis identifies cuproptosis-related gene DLAT as a potential prognostic and immunological biomarker in pancreatic adenocarcinoma. Zhang X; Zhou Y; Hu J; Yu X; Xu H; Ba Z; Zhang H; Sun Y; Wang R; Du X; Mou R; Li X; Zhu J; Xie R BMC Cancer; 2023 Jun; 23(1):560. PubMed ID: 37330494 [TBL] [Abstract][Full Text] [Related]
52. An original cuproptosis-related genes signature effectively influences the prognosis and immune status of head and neck squamous cell carcinoma. Zheng X; Zhang C; Zheng D; Guo Q; Maierhaba M; Xue L; Zeng X; Wu Y; Gao W Front Genet; 2022; 13():1084206. PubMed ID: 36685880 [No Abstract] [Full Text] [Related]
53. Single-cell and bulk RNA-seq unveils the immune infiltration landscape associated with cuproptosis in cerebral cavernous malformations. Chen C; Bao Y; Ju S; Jiang C; Zou X; Zhang X; Chen L Biomark Res; 2024 Jun; 12(1):57. PubMed ID: 38835051 [TBL] [Abstract][Full Text] [Related]
54. Identification of cuproptosis-related subtypes in lung adenocarcinoma and its potential significance. Pan S; Song C; Meng H; Li N; Li D; Hao B; Lu Z; Geng Q Front Pharmacol; 2022; 13():934722. PubMed ID: 36263125 [TBL] [Abstract][Full Text] [Related]
55. A cuproptosis-related signature for predicting the prognosis of gastric cancer. He C; Zhang H; Guo Z; Mo Z J Gastrointest Oncol; 2023 Feb; 14(1):146-164. PubMed ID: 36915443 [TBL] [Abstract][Full Text] [Related]
56. Comprehensive bioinformatics analysis to identify a novel cuproptosis-related prognostic signature and its ceRNA regulatory axis and candidate traditional Chinese medicine active ingredients in lung adenocarcinoma. Wang S; Xing N; Meng X; Xiang L; Zhang Y Front Pharmacol; 2022; 13():971867. PubMed ID: 36110528 [TBL] [Abstract][Full Text] [Related]
57. Development and validation of a novel diagnostic model for musculoskeletal aging (sarcopenia) based on cuproptosis-related genes associated with immunity. Lin S; Huang H; Ling M; Zhang C; Yang F; Fan Y Am J Transl Res; 2022; 14(12):8523-8538. PubMed ID: 36628249 [TBL] [Abstract][Full Text] [Related]
58. The role of a cuproptosis-related prognostic signature in colon cancer tumor microenvironment and immune responses. Xu C; Liu Y; Zhang Y; Gao L Front Genet; 2022; 13():928105. PubMed ID: 36313449 [No Abstract] [Full Text] [Related]
59. Bioinformatics Prediction and Experimental Validation Identify a Novel Cuproptosis-Related Gene Signature in Human Synovial Inflammation during Osteoarthritis Progression. Wang W; Chen Z; Hua Y Biomolecules; 2023 Jan; 13(1):. PubMed ID: 36671512 [TBL] [Abstract][Full Text] [Related]
60. Crosstalk of cuproptosis-related subtypes, establishment of a prognostic signature, and immune infiltration characteristics in gastric cancer. Wang Y; Guo F; Song W; Guo W; Shao J; Liu Y Heliyon; 2024 Jan; 10(2):e24411. PubMed ID: 38298669 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]